Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis (NCT04399941)
Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
🩺 Plain-English Summary (8th-Grade Level)
Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (1 items).
Location: Boston Medical Center — Boston, Massachusetts
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
- Venography (DIAGNOSTIC_TEST)
- Intravascular ultrasound (IVUS) (DIAGNOSTIC_TEST)
- Image processing (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Boston Medical Center — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 638-7330
Email: vipul.chitalia@bmc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Renal Disease
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis — Washington D.C., District of Columbia
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients — Dallas, Texas
- An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL — Winnipeg, Manitoba
- The Effect of a Prehabilitation Exercise Program on Physical Functioning for Patients Undergoing Kidney Transplantation — Vancouver, British Columbia
- Light Therapy in End Stage Kidney Disease — Philadelphia, Pennsylvania
Explore by condition: All End Stage Renal Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.